018680 — Seoul Pharma Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Seoul Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	236	-1,342	-9,689	855	3,517
Depreciation
Amortisation
Non-Cash Items	5,587	6,349	5,622	2,159	2,314
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-5,296	-1,714	-136	-5,705	-2,495
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	2,929	5,737	-1,675	-78.2	5,265
Capital Expenditures	-156	-671	-1,168	-1,299	-1,894
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	3,473	378	68.2	-33	-3,968
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	3,316	-293	-1,099	-1,332	-5,862
Financing Cash Flow Items	24	-0.722	0	-8.94	0
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-3,314	2,005	1,535	-483	-4,466
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	2,931	7,392	-1,237	-2,092	-5,155